$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells 원문보기

Cancer biology & therapy, v.13 no.13, 2012년, pp.1307 - 1318  

Kim, Jae-Sung (Division of Radiation Cancer Biology) ,  Yun, Hong Shik (Korea Institute of Radiological and Medical Sciences) ,  Um, Hong-Duck (Seoul, South Korea) ,  Park, Jong Kuk (Division of Radiation Cancer Biology) ,  Lee, Kee-Ho (Korea Institute of Radiological and Medical Sciences) ,  Kang, Chang-Mo (Seoul, South Korea) ,  Lee, Su-Jae (Division of Radiation Cancer Biology) ,  Hwang, Sang-Gu (Korea Institute of Radiological and Medical Sciences)

Abstract AI-Helper 아이콘AI-Helper

Although tumor resistance remains a significant impediment to successful radiotherapy, associated regulatory markers and detailed molecular mechanisms underlying this phenomenon are not well defined. In this study, we identified inositol polyphosphate 4-phosphatase type II (INPP4B) as a novel marker...

주제어

참고문헌 (44)

  1. 1 Parkin DM Bray F Ferlay J Pisani P Estimating the world cancer burden: Globocan 2000 Int J Cancer 2001 94 153 6 10.1002/ijc.1440 11668491 

  2. 2 Lefebvre JL Laryngeal preservation in head and neck cancer: multidisciplinary approach Lancet Oncol 2006 7 747 55 10.1016/S1470-2045(06)70860-9 16945770 

  3. 3 Nix PA Greenman J Cawkwell L Stafford N Radioresistant laryngeal cancer: beyond the TNM stage Clin Otolaryngol Allied Sci 2004 29 105 14 10.1046/j.1365-2273.2003.00796.x 15113291 

  4. 4 Kim JJ Tannock IF Repopulation of cancer cells during therapy: an important cause of treatment failure Nat Rev Cancer 2005 5 516 25 10.1038/nrc1650 15965493 

  5. 5 Bussink J van der Kogel AJ Kaanders JH Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer Lancet Oncol 2008 9 288 96 10.1016/S1470-2045(08)70073-1 18308254 

  6. 6 Haffty BG Glazer PM Molecular markers in clinical radiation oncology Oncogene 2003 22 5915 25 10.1038/sj.onc.1206704 12947398 

  7. 7 Kumar B Cordell KG D’Silva N Prince ME Adams ME Fisher SG Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer Arch Otolaryngol Head Neck Surg 2008 134 363 9 10.1001/archotol.134.4.363 18427001 

  8. 8 Wang T Tamae D LeBon T Shively JE Yen Y Li JJ The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells Cancer Res 2005 65 10338 46 10.1158/0008-5472.CAN-04-4614 16288023 

  9. 9 Guo G Yan-Sanders Y Lyn-Cook BD Wang T Tamae D Ogi J Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses Mol Cell Biol 2003 23 2362 78 10.1128/MCB.23.7.2362-2378.2003 12640121 

  10. 10 Hill BT Deuchars K Hosking LK Ling V Whelan RD Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro J Natl Cancer Inst 1990 82 607 12 10.1093/jnci/82.7.607 1968980 

  11. 11 Henness S Davey MW Harvie RM Davey RA Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression Int J Radiat Oncol Biol Phys 2002 54 895 902 10.1016/S0360-3016(02)03037-7 12377343 

  12. 12 Ryu JS Um JH Kang CD Bae JH Kim DU Lee YJ Fractionated irradiation leads to restoration of drug sensitivity in MDR cells that correlates with down-regulation of P-gp and DNA-dependent protein kinase activity Radiat Res 2004 162 527 35 10.1667/RR3260 15624307 

  13. 13 Bottke D Koychev D Busse A Heufelder K Wiegel T Thiel E Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines Radiat Res 2008 170 41 8 10.1667/RR0986.1 18582150 

  14. 14 Seve M Chimienti F Devergnas S Favier A In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters’ tissue expression BMC Genomics 2004 5 32 10.1186/1471-2164-5-32 15154973 

  15. 15 Oh J Lee J Woo JM Choi E Park I Han C Systematic identification and integrative analysis of novel genes expressed specifically or predominantly in mouse epididymis BMC Genomics 2006 7 314 10.1186/1471-2164-7-314 17166261 

  16. 16 Kim JS Ryoo ZY Chun JS Cytokine-like 1 (Cytl1) regulates the chondrogenesis of mesenchymal cells J Biol Chem 2007 282 29359 67 10.1074/jbc.M700965200 17644814 

  17. 17 Kim JS Chang JW Yun HS Yang KM Hong EH Kim DH Chloride intracellular channel 1 identified using proteomic analysis plays an important role in the radiosensitivity of HEp-2 cells via reactive oxygen species production Proteomics 2010 10 2589 604 10.1002/pmic.200900523 20461716 

  18. 18 Norris FA Auethavekiat V Majerus PW The isolation and characterization of cDNA encoding human and rat brain inositol polyphosphate 4-phosphatase J Biol Chem 1995 270 16128 33 10.1074/jbc.270.27.16128 7608176 

  19. 19 Norris FA Atkins RC Majerus PW The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family J Biol Chem 1997 272 23859 64 10.1074/jbc.272.38.23859 9295334 

  20. 20 Gewinner C Wang ZC Richardson A Teruya-Feldstein J Etemadmoghadam D Bowtell D Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling Cancer Cell 2009 16 115 25 10.1016/j.ccr.2009.06.006 19647222 

  21. 21 Di Paolo G De Camilli P Phosphoinositides in cell regulation and membrane dynamics Nature 2006 443 651 7 10.1038/nature05185 17035995 

  22. 22 Kok K Geering B Vanhaesebroeck B Regulation of phosphoinositide 3-kinase expression in health and disease Trends Biochem Sci 2009 34 115 27 10.1016/j.tibs.2009.01.003 19299143 

  23. 23 Wymann MP Schneiter R Lipid signalling in disease Nat Rev Mol Cell Biol 2008 9 162 76 10.1038/nrm2335 18216772 

  24. 24 Barnache S Le Scolan E Kosmider O Denis N Moreau-Gachelin F Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene Oncogene 2006 25 1420 3 10.1038/sj.onc.1209187 16247441 

  25. 25 Duan S Bleibel WK Huang RS Shukla SJ Wu X Badner JA Mapping genes that contribute to daunorubicin-induced cytotoxicity Cancer Res 2007 67 5425 33 10.1158/0008-5472.CAN-06-4431 17545624 

  26. 26 Jung JJ Jeung HC Chung HC Lee JO Kim TS Kim YT In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer Genomics 2009 93 52 61 10.1016/j.ygeno.2008.08.002 18804159 

  27. 27 Dent P Yacoub A Fisher PB Hagan MP Grant S MAPK pathways in radiation responses Oncogene 2003 22 5885 96 10.1038/sj.onc.1206701 12947395 

  28. 28 Das AK Sato M Story MD Peyton M Graves R Redpath S Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation Cancer Res 2006 66 9601 8 10.1158/0008-5472.CAN-06-2627 17018617 

  29. 29 Rho JK Choi YJ Ryoo BY Na II Yang SH Kim CH p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer Cancer Res 2007 67 1163 9 10.1158/0008-5472.CAN-06-2037 17283151 

  30. 30 Huang WC Hung MC Induction of Akt activity by chemotherapy confers acquired resistance J Formos Med Assoc 2009 108 180 94 10.1016/S0929-6646(09)60051-6 19293033 

  31. 31 Vivanco I Sawyers CL The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2002 2 489 501 10.1038/nrc839 12094235 

  32. 32 Ugi S Imamura T Maegawa H Egawa K Yoshizaki T Shi K Protein phosphatase 2A negatively regulates insulin’s metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes Mol Cell Biol 2004 24 8778 89 10.1128/MCB.24.19.8778-8789.2004 15367694 

  33. 33 Trotman LC Alimonti A Scaglioni PP Koutcher JA Cordon-Cardo C Pandolfi PP Identification of a tumour suppressor network opposing nuclear Akt function Nature 2006 441 523 7 10.1038/nature04809 16680151 

  34. 34 Gottesman MM Fojo T Bates SE Multidrug resistance in cancer: role of ATP-dependent transporters Nat Rev Cancer 2002 2 48 58 10.1038/nrc706 11902585 

  35. 35 Evans A Bates V Troy H Hewitt S Holbeck S Chung YL Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies Cancer Chemother Pharmacol 2008 61 377 93 10.1007/s00280-007-0480-1 17520257 

  36. 36 Vordermark D Brown JM Endogenous markers of tumor hypoxia predictors of clinical radiation resistance? Strahlenther Onkol 2003 179 801 11 10.1007/s00066-003-1150-9 14652668 

  37. 37 Pan JS Cai JY Xie CX Zhou F Zhang ZP Dong J Interacting with HBsAg compromises resistance of jumping translocation breakpoint protein to ultraviolet radiation-induced apoptosis in 293FT cells Cancer Lett 2009 285 151 6 10.1016/j.canlet.2009.05.009 19487072 

  38. 38 Jung EU Yoon JH Lee YJ Lee JH Kim BH Yu SJ Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells Cancer Lett 2010 298 9 15 10.1016/j.canlet.2010.05.020 20573444 

  39. 39 Sasaki J Kofuji S Itoh R Momiyama T Takayama K Murakami H The PtdIns(3,4)P(2) phosphatase INPP4A is a suppressor of excitotoxic neuronal death Nature 2010 465 497 501 10.1038/nature09023 20463662 

  40. 40 Nystuen A Legare ME Shultz LD Frankel WN A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice Neuron 2001 32 203 12 10.1016/S0896-6273(01)00468-8 11683991 

  41. 41 Salmena L Carracedo A Pandolfi PP Tenets of PTEN tumor suppression Cell 2008 133 403 14 10.1016/j.cell.2008.04.013 18455982 

  42. 42 Agoulnik IU Hodgson MC Bowden WA Ittmann MM INPP4B: the new kid on the PI3K block Oncotarget 2011 2 321 8 21487159 

  43. 43 Kisseleva MV Cao L Majerus PW Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death J Biol Chem 2002 277 6266 72 10.1074/jbc.M105969200 11706019 

  44. 44 Kim JS Park ZY Yoo YJ Yu SS Chun JS p38 kinase mediates nitric oxide-induced apoptosis of chondrocytes through the inhibition of protein kinase C zeta by blocking autophosphorylation Cell Death Differ 2005 12 201 12 10.1038/sj.cdd.4401511 15665819 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로